Posted On: 06/21/2014 9:21:22 AM
Post# of 45026
$ENZN Recent News
Cancer drug test results send CytRx shares soaring by 75% 11:48 a.m. Dec. 11, 2013 - Russ Britt
5 activist hedge funds to watch 12:17 p.m. Oct. 15, 2013 - Insider Monkey
Enzon to partner with China's Hisun 1:06 p.m. May 7, 2012 - MarketWatch.com
Stocks to watch Friday: McDonald’s, TriQuint 7:11 a.m. Sept. 23, 2011 - MarketWatch
Proxy firm backs Forest Labs' entire board slate 12:56 p.m. Aug. 10, 2011 - MarketWatch.com
Monday's biggest gaining and declining stocks 5:41 p.m. Nov. 9, 2009 - MarketWatch
Enzon to sell specialty pharmaceuticals business 9:47 a.m. Nov. 9, 2009 - MarketWatch
Enzon sells specialty pharma business for $327M 9:34 a.m. Nov. 9, 2009 - Michelle Donley
Drug stocks gain, Enzon rises on divestiture news 1:17 p.m. Aug. 11, 2008 - Val Brickates Kennedy
Drug stocks slip, but earnings boost Charles River 2:31 p.m. May 7, 2008 - Val Brickates Kennedy
CORRECT: Carl Icahn acquires 6.93% stake in Enzon 1:12 p.m. March 14, 2008 - Wallace Witkowski
CORRECT:Icahn suggests Enzon consider strategic review, sale 1:08 p.m. March 14, 2008 - Wallace Witkowski
CORRECT: Icahn buys Enzon stake because shares undervalued 1:07 p.m. March 14, 2008 - Wallace Witkowski
CORRECT: Carl Icahn acquires 6.93% stake in Enzon 1:05 p.m. March 14, 2008 - Wallace Witkowski
Drug and biotech shares rise, Palatin jumps on data 9:47 a.m. Sept. 27, 2007 - Angela Moore
Drug stocks flat; Enzon climbs for second day 1:08 p.m. Aug. 21, 2007 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 4:32 p.m. Aug. 20, 2007 - MarketWatch
Drug stocks mixed; Novo-Nordisk gains on drug data 1:38 p.m. Aug. 20, 2007 - Val Brickates Kennedy
Enzon sells 25% of Peg-intron royalty interest for $93 mln 9:03 a.m. Aug. 20, 2007 - Val Brickates Kennedy
Icahn group discloses investment holdings 8:06 a.m. Aug. 15, 2007 - MarketWatch.com
Tracking Carl Icahn's Portfolio - Q1 2014 Update 1:46 a.m. May 20, 2014 - Seeking Alpha
Baupost's Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals 5:43 p.m. May 12, 2014 - GuruFocus.com
Looking For Value Among Biotechs After Precipitous Declines In Stock Price 12:26 p.m. March 24, 2014 - Seeking Alpha
Tracking Carl Icahn's Portfolio - Q4 2013 Update 1:25 a.m. Feb. 18, 2014 - Seeking Alpha
Tracking Seth Klarman's Baupost Group Holdings - Q4 2013 Update 4:01 a.m. Feb. 14, 2014 - Seeking Alpha
Warning! Enzon Pharmaceuticals Is Definitely Going To $0 8:52 a.m. Jan. 14, 2014 - Seeking Alpha
Ranking 50 Stocks By Free Cash Flow Yield 8:05 a.m. Nov. 26, 2013 - Seeking Alpha
Tracking Carl Icahn's Portfolio - Q3 2013 Update 11:05 a.m. Nov. 18, 2013 - Seeking Alpha
10-Q: ENZON PHARMACEUTICALS INC 5:35 p.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
What's Left Of Enzon Pharmaceuticals? 7:53 a.m. Sept. 30, 2013 - Seeking Alpha
Billionaires Hold Bargains, 40% Off or More 7:14 p.m. Sept. 11, 2013 - GuruFocus.com
Tracking Carl Icahn's Portfolio - Q2 2013 Update 8:03 a.m. Aug. 23, 2013 - Seeking Alpha
Tracking Seth Klarman's Baupost Group Holdings - Q2 2013 Update 12:57 p.m. Aug. 14, 2013 - Seeking Alpha
Charles Brandes Top Second Quarter Portfolio Changes 6:49 p.m. Aug. 9, 2013 - GuruFocus.com
Complete Seth Klarman And Baupost Group Portfolio Update 4:46 p.m. May 15, 2013 - Seeking Alpha
Tracking Seth Klarman's Baupost Group Holdings - Q1 2013 Update 5:33 a.m. May 15, 2013 - Seeking Alpha
Billionaire Seth Klarman's Long-Term Stock Picks 4:04 p.m. May 13, 2013 - Seeking Alpha
Seth Klarman's Worst Performing Stock Picks Year-To-Date 12:35 p.m. May 13, 2013 - Seeking Alpha
10-Q: ENZON PHARMACEUTICALS INC 4:39 p.m. May 10, 2013 - Edgar Online - (EDG = 10Q, 10K)
A Review Of Seth Klarman's Baupost Group's Q4 U.S. Equity Changes 2:58 p.m. Feb. 18, 2013 - Seeking Alpha
Enzon Adopts Stockholder Rights Plan in an Effort to Protect Net Operating Loss Carryforwards 8:32 a.m. May 1, 2014 - BusinessWire - BZX
Annual Changes to the NASDAQ Biotechnology Index 9:05 a.m. Dec. 16, 2013 - GlobeNewswire
Arthur J. Higgins Joins Endo Board of Directors 10:50 p.m. Dec. 10, 2013 - PR Newswire
Santaris Pharma A/S resumes full ownership of cancer programs licensed to Enzon Pharmaceutical Inc. 8:00 a.m. Oct. 28, 2013 - PR Newswire
Cancer drug test results send CytRx shares soaring by 75% 11:48 a.m. Dec. 11, 2013 - Russ Britt
5 activist hedge funds to watch 12:17 p.m. Oct. 15, 2013 - Insider Monkey
Enzon to partner with China's Hisun 1:06 p.m. May 7, 2012 - MarketWatch.com
Stocks to watch Friday: McDonald’s, TriQuint 7:11 a.m. Sept. 23, 2011 - MarketWatch
Proxy firm backs Forest Labs' entire board slate 12:56 p.m. Aug. 10, 2011 - MarketWatch.com
Monday's biggest gaining and declining stocks 5:41 p.m. Nov. 9, 2009 - MarketWatch
Enzon to sell specialty pharmaceuticals business 9:47 a.m. Nov. 9, 2009 - MarketWatch
Enzon sells specialty pharma business for $327M 9:34 a.m. Nov. 9, 2009 - Michelle Donley
Drug stocks gain, Enzon rises on divestiture news 1:17 p.m. Aug. 11, 2008 - Val Brickates Kennedy
Drug stocks slip, but earnings boost Charles River 2:31 p.m. May 7, 2008 - Val Brickates Kennedy
CORRECT: Carl Icahn acquires 6.93% stake in Enzon 1:12 p.m. March 14, 2008 - Wallace Witkowski
CORRECT:Icahn suggests Enzon consider strategic review, sale 1:08 p.m. March 14, 2008 - Wallace Witkowski
CORRECT: Icahn buys Enzon stake because shares undervalued 1:07 p.m. March 14, 2008 - Wallace Witkowski
CORRECT: Carl Icahn acquires 6.93% stake in Enzon 1:05 p.m. March 14, 2008 - Wallace Witkowski
Drug and biotech shares rise, Palatin jumps on data 9:47 a.m. Sept. 27, 2007 - Angela Moore
Drug stocks flat; Enzon climbs for second day 1:08 p.m. Aug. 21, 2007 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 4:32 p.m. Aug. 20, 2007 - MarketWatch
Drug stocks mixed; Novo-Nordisk gains on drug data 1:38 p.m. Aug. 20, 2007 - Val Brickates Kennedy
Enzon sells 25% of Peg-intron royalty interest for $93 mln 9:03 a.m. Aug. 20, 2007 - Val Brickates Kennedy
Icahn group discloses investment holdings 8:06 a.m. Aug. 15, 2007 - MarketWatch.com
Tracking Carl Icahn's Portfolio - Q1 2014 Update 1:46 a.m. May 20, 2014 - Seeking Alpha
Baupost's Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals 5:43 p.m. May 12, 2014 - GuruFocus.com
Looking For Value Among Biotechs After Precipitous Declines In Stock Price 12:26 p.m. March 24, 2014 - Seeking Alpha
Tracking Carl Icahn's Portfolio - Q4 2013 Update 1:25 a.m. Feb. 18, 2014 - Seeking Alpha
Tracking Seth Klarman's Baupost Group Holdings - Q4 2013 Update 4:01 a.m. Feb. 14, 2014 - Seeking Alpha
Warning! Enzon Pharmaceuticals Is Definitely Going To $0 8:52 a.m. Jan. 14, 2014 - Seeking Alpha
Ranking 50 Stocks By Free Cash Flow Yield 8:05 a.m. Nov. 26, 2013 - Seeking Alpha
Tracking Carl Icahn's Portfolio - Q3 2013 Update 11:05 a.m. Nov. 18, 2013 - Seeking Alpha
10-Q: ENZON PHARMACEUTICALS INC 5:35 p.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
What's Left Of Enzon Pharmaceuticals? 7:53 a.m. Sept. 30, 2013 - Seeking Alpha
Billionaires Hold Bargains, 40% Off or More 7:14 p.m. Sept. 11, 2013 - GuruFocus.com
Tracking Carl Icahn's Portfolio - Q2 2013 Update 8:03 a.m. Aug. 23, 2013 - Seeking Alpha
Tracking Seth Klarman's Baupost Group Holdings - Q2 2013 Update 12:57 p.m. Aug. 14, 2013 - Seeking Alpha
Charles Brandes Top Second Quarter Portfolio Changes 6:49 p.m. Aug. 9, 2013 - GuruFocus.com
Complete Seth Klarman And Baupost Group Portfolio Update 4:46 p.m. May 15, 2013 - Seeking Alpha
Tracking Seth Klarman's Baupost Group Holdings - Q1 2013 Update 5:33 a.m. May 15, 2013 - Seeking Alpha
Billionaire Seth Klarman's Long-Term Stock Picks 4:04 p.m. May 13, 2013 - Seeking Alpha
Seth Klarman's Worst Performing Stock Picks Year-To-Date 12:35 p.m. May 13, 2013 - Seeking Alpha
10-Q: ENZON PHARMACEUTICALS INC 4:39 p.m. May 10, 2013 - Edgar Online - (EDG = 10Q, 10K)
A Review Of Seth Klarman's Baupost Group's Q4 U.S. Equity Changes 2:58 p.m. Feb. 18, 2013 - Seeking Alpha
Enzon Adopts Stockholder Rights Plan in an Effort to Protect Net Operating Loss Carryforwards 8:32 a.m. May 1, 2014 - BusinessWire - BZX
Annual Changes to the NASDAQ Biotechnology Index 9:05 a.m. Dec. 16, 2013 - GlobeNewswire
Arthur J. Higgins Joins Endo Board of Directors 10:50 p.m. Dec. 10, 2013 - PR Newswire
Santaris Pharma A/S resumes full ownership of cancer programs licensed to Enzon Pharmaceutical Inc. 8:00 a.m. Oct. 28, 2013 - PR Newswire
(0)
(0)
